Maculoplasty for age-related macular degeneration: Reengineering Bruch's membrane and the human macula

Progress in Retinal and Eye Research

Volumn 25, Issue 6, 2006, Pages 539-562

  Del Priore, Lucian V ^a   Tezel, Tongalp H ^b   Kaplan, Henry J ^b  

^a New York Presbyterian Hospital   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; INTEGRIN;

ANATOMY; APOPTOSIS; AUTOGRAFT; BLINDNESS; BRUCH MEMBRANE; CELL ADHESION; CELL FATE; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELL ULTRASTRUCTURE; EXTRACELLULAR MATRIX; EXUDATE; HUMAN; MACULOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA SURGERY; REVIEW; SURGICAL TECHNIQUE; TISSUE CULTURE; TISSUE ENGINEERING; TREATMENT OUTCOME;

BRUCH MEMBRANE; CELL TRANSPLANTATION; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; TISSUE ENGINEERING; TREATMENT OUTCOME;

EID: 33750523637     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2006.08.001     Document Type: Review

References (183)

1. Abe T., Tomita H., et al. Characterization of iris pigment epithelial cell for auto cell transplantation. Cell Transplant 8 5 (1999) 501-510
2. Abe T., Yoshida M., et al. Functional analysis after auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration. Tohoku J. Exp. Med. 189 4 (1999) 295-305
3. Abe T., Tomita H., et al. Autologous iris pigment epithelial cell transplantation in monkey subretinal region. Curr. Eye Res. 20 4 (2000) 268-275
4. Abe T., Yoshida M., et al. Auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration: short-term results. Tohoku J. Exp. Med. 191 1 (2000) 7-20
5. Adamis A.P., Altaweel M., et al. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 113 1 (2006) 23-28
6. Aisenbrey S., and Bartz-Schmidt U. Macular translocation with 360-degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am. J. Ophthalmol. 135 5 (2003) 748-749 (author reply 749)
7. Akduman L., Del Priore L.V., et al. Perfusion of the subfoveal choriocapillaris affects visual recovery after submacular surgery in presumed ocular histoplasmosis syndrome. Am. J. Ophthalmol. 123 1 (1997) 90-96
8. Algvere P.V., Berglin L., et al. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes. Arch. Clin. Exp. Ophthalmol. 232 12 (1994) 707-716
9. Algvere P.V., Berglin L., et al. Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy. Graefes. Arch. Clin. Exp. Ophthalmol. 235 3 (1997) 149-158
10. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens. 21 1 (2003) 3-12
11. Augustin A.J., and Schmidt-Erfurth U. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Am. J. Ophthalmol. 141 4 (2006) 638-645
12. Augustin A.J., and Schmidt-Erfurth U. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology 113 1 (2006) 14-22
13. Avery N.C., and Bailey A.J. Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: relevance to aging and exercise. Scand. J. Med. Sci. Sports 15 4 (2005) 231-240
14. Avery R.L., and Glaser B.M. Inhibition of retinal pigment epithelial cell attachment by a synthetic peptide derived from the cell-binding domain of fibronectin. Arch. Ophthalmol. 104 8 (1986) 1220-1222
15. Avery R.L., Pieramici D.J., et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113 3 (2006) 363-372 (e5)
16. Bakri S.J., Cameron J.D., et al. Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model. Am. J. Ophthalmol. 142 1 (2006) 162-164
17. Bentley J.P. Aging of collagen. J. Invest. Dermatol. 73 1 (1979) 80-83
18. Berger A.S., and Kaplan H.J. Clinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative results. Ophthalmology 99 6 (1992) 969-975 (discussion 975-6)
19. Berger A.S., Tezel T.H., et al. Photoreceptor transplantation in retinitis pigmentosa: short-term follow-up. Ophthalmology 110 2 (2003) 383-391
20. Bergink G.J., Hoyng C.B., et al. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation. Graefes Arch. Clin. Exp. Ophthalmol. (Graefes Arch. Klin. Exp. Ophthalmol.) 236 5 (1998) 321-325
21. Bhutto I.A., Kim S.Y., et al. Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest. Ophthalmol. Visual Sci. 45 5 (2004) 1544-1552
22. Binder S., Stolba U., et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am. J. Ophthalmol. 133 2 (2002) 215-225
23. Bottoni F., Romano M., et al. Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy. Graefes Arch. Clin. Exp. Ophthalmol. (2006)
24. Bressler N.M., Bressler S.B., et al. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1. Am. J. Ophthalmol. 130 4 (2000) 387-407
25. Cai H., and Del Priore L.V. Bruch membrane aging alters the gene expression profile of human retinal pigment epithelium. Curr. Eye Res. 31 2 (2006) 181-189
26. Cai H., and Del Priore L.V. Gene expression profile of cultured adult compared to immortalized human RPE. Mol. Vision 12 (2006) 1-14
27. Chang A.A., Tan W., et al. Limited macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration. Clin. Exp. Ophthalmol. 31 2 (2003) 103-109
28. Chen L., Miyamura N., et al. Distribution of the collagen IV isoforms in human Bruch's membrane. Br. J. Ophthalmol. 87 2 (2003) 212-215
29. Chu P., and Grunwald G.B. Identification of the 2A10 antigen of retinal pigment epithelium as a beta 1 subunit of integrin. Invest. Ophthalmol. Visual Sci. 32 6 (1991) 1757-1762
30. Chu P.G., and Grunwald G.B. Functional inhibition of retinal pigment epithelial cell-substrate adhesion with a monoclonal antibody against the beta 1 subunit of integrin. Invest. Ophthalmol. Visual Sci. 32 6 (1991) 1763-1769
31. Conti S.M., and Kertes P.J. The use of intravitreal corticosteroids, evidence-based and otherwise. Curr. Opin. Ophthalmol. 17 3 (2006) 235-244
32. Coscas G., and Meunier I. [Surgery of macular neovascular subretinal membranes]. J. Fr. Ophtalmol. 16 11 (1993) 633-641
33. Crafoord S., Geng L., et al. Experimental transplantation of autologous iris pigment epithelial cells to the subretinal space. Acta Ophthalmol. Scand. 79 5 (2001) 509-514
34. Crafoord S., Geng L., et al. Photoreceptor survival in transplantation of autologous iris pigment epithelial cells to the subretinal space. Acta Ophthalmol. Scand. 80 4 (2002) 387-394
35. Cunningham Jr. E.T., Adamis A.P., et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112 10 (2005) 1747-1757
36. D'Amico D.J., and Friberg T.R. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am. J. Ophthalmol. 132 2 (2001) 289-290
37. D'Amico D.J., Goldberg M.F., et al. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy. Retina (Philadelphia, Pa.) 23 1 (2003) 14-23
38. D'Amico D.J., Patel M., et al. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113 6 (2006) 1001 (e1-6)
39. Das A., Frank R.N., et al. Ultrastructural localization of extracellular matrix components in human retinal vessels and Bruch's membrane. Arch. Ophthalmol. 108 3 (1990) 421-429
40. de Juan Jr. E., and Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am. J. Ophthalmol. 105 1 (1988) 25-29
41. Deberg M., Labasse A., et al. New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthr. Cartilage 13 3 (2005) 258-265
42. Degenring R.F., and Jonas J.B. Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization. Acta Ophthalmol. Scand. 83 5 (2005) 621
43. Del Priore L.V. Effect of sham surgery on retinal function after subretinal transplantation of the artificial silicone retina. Arch. Ophthalmol. 123 8 (2005) 1156 (author reply 1156-7)
44. Del Priore L.V., and Tezel T.H. Reattachment rate of human retinal pigment epithelium to layers of human Bruch's membrane. Arch. Ophthalmol. 116 3 (1998) 335-341
45. Del Priore L.V., Kaplan H.J., et al. Experimental and surgical aspects of retinal pigment epithelial cell transplantation. Eur. J. Implant Ref. Surg. 5 (1993) 128-132
46. Del Priore L.V., Hornbeck R., et al. Debridement of the pig retinal pigment epithelium in vivo. Arch. Ophthalmol. 113 7 (1995) 939-944
47. Del Priore L.V., Kaplan H.J., et al. Retinal pigment epithelial trnasplantation inthe magagement of subfoveal choroidal neovascularization. Semin. Ophthalmol. 12 (1997) 45-55
48. Del Priore L.V., Tezel T.H., et al. Retinal Pigment Epithelial Transplantation for Subfoveal Choroidal Neovascularization: Clinical and Laboratory Studies. Vitreo-Retinal and Uveitis Update. The 47th Annual Symposium of the New Orleans Academy of Ophthalmology (1998), Kugler Publications, The Hague, The Netherlands
49. Del Priore, L.V., Tezel, T.H., et al., 1998b. The role of Bruch's membrane in survival of transplanted retinal pigment epithelium. First International Conference on New Developments in the Treatment of Age-related Macular Degeneration.
50. Del Priore, L.V., Tezel, T.H., et al., 1999. Retinal pigment epithelial transplantation in exudative age-related macular degeneration: What do in vivo and in vitro studies teach us? In: Coscas, G., Cardillo F., Piccolino, F., (Eds.), Retinal Pigment Epithelium and Macular Diseases, Documenta Ophthalmologica Proceeedings Series 62. Kluwer Academic Publishers, Dordrecht, pp. 125-134.
51. Del Priore L.V., Kaplan H.J., et al. Retinal pigment epithelial cell transplantation after subfoveal membranectomy in age-related macular degeneration: clinicopathologic correlation. Am. J. Ophthalmol. 131 4 (2001) 472-480
52. Del Priore L.V., Geng L., et al. Extracellular matrix ligands promote RPE attachment to inner Bruch's membrane. Curr. Eye Res. 25 2 (2002) 79-89
53. Del Priore L.V., Tezel T.H., et al. Survival of allogeneic porcine retinal pigment epithelial sheets after subretinal transplantation. Invest. Ophthalmol. Visual Sci. 45 3 (2004) 985-992
54. Desai V.N., Del Priore L.V., et al. Choriocapillaris atrophy after submacular surgery in presumed ocular histoplasmosis syndrome. Arch. Ophthalmol. 113 4 (1995) 408-409
55. Donahue S.P., Wall M., et al. Interferon treatment of SRNV. Ophthalmology 101 4 (1994) 624-625
56. Engler C.B., Sander B., et al. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation. Acta Ophthalmol. (Copenh.) 71 1 (1993) 27-31
57. Ergun E., Maar N., et al. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration. Am. J. Ophthalmol. 142 1 (2006) 10-16
58. Fariss R.N., Apte S.S., et al. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am. J. Pathol. 150 1 (1997) 323-328
59. Fariss R.N., Apte S.S., et al. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br. J. Ophthalmol. 82 11 (1998) 1329-1334
60. Finger P.T., Chakravarthy U., et al. Radiotherapy and the treatment of age-related macular degeneration. External beam radiation therapy is effective in the treatment of age-related macular degeneration. Arch. Ophthalmol. 116 11 (1998) 1507-1511
61. Fraunfelder F.W. Pegaptanib for wet macular degeneration. Drugs Today (Barc) 41 11 (2005) 703-709
62. Freund K.B., Klais C.M., et al. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch. Ophthalmol. 124 4 (2006) 487-492
63. Fujii K., Kuboki Y., et al. Aging of human bone and articular cartilage collagen: changes in the reducible cross-links and their precursors. Gerontology 22 5 (1976) 363-370
64. Fujii G.Y., Humayun M.S., et al. Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration. Am. J. Ophthalmol. 131 1 (2001) 90-100
65. Fujii G.Y., de Juan Jr. E., et al. Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report. Am. J. Ophthalmol. 134 1 (2002) 69-74
66. Fujii G.Y., de Juan Jr. E., et al. Limited macular translocation for the management of subfoveal choroidal neovascularization after photodynamic therapy. Am. J. Ophthalmol. 135 1 (2003) 109-112
67. Fung W.E. Interferon alpha 2a for treatment of age-related macular degeneration. Am. J. Ophthalmol. 112 3 (1991) 349-350
68. Gaudreault J., Fei D., et al. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. Invest. Ophthalmol. Visual Sci. 46 2 (2005) 726-733
69. Geng L., Del Priore L.V., et al. Resurfacing of elastin layer and inner collagen layer of human Bruch's membrane In vitro [abstracts]. Invest. Ophthalmol. Visual Sci. May (2001)
70. Glacet-Bernard A., Simon P., et al. Translocation of the macula for management of subfoveal choroidal neovascularization: comparison of results in age-related macular degeneration and degenerative myopia. Am. J. Ophthalmol. 131 1 (2001) 78-89
71. Gonzales C.R. Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis. Retina 25 7 (2005) 815-827
72. Gouras P., and Algvere P. Retinal cell transplantation in the macula: new techniques. Vision Res. 36 24 (1996) 4121-4125
73. Gragoudas E.S., Adamis A.P., et al. Pegaptanib for neovascular age-related macular degeneration. N. Engl. J. Med. 351 27 (2004) 2805-2816
74. Green W.R., and Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 100 10 (1993) 1519-1535
75. Green W.R., and Key III S.N. Senile macular degeneration: a histopathologic study. Trans. Am. Ophthalmol. Soc. 75 (1977) 180-254
76. Green W.R., McDonnell P.J., et al. Pathologic features of senile macular degeneration. Ophthalmology 92 5 (1985) 615-627
77. Grossniklaus H.E., and Green W.R. Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular Surgery Trials Research Group. Arch. Ophthalmol. 116 6 (1998) 745-749
78. Grossniklaus H.E., Hutchinson A.K., et al. Clinicopathologic features of surgically excised choroidal neovascular membranes. Ophthalmology 101 6 (1994) 1099-1111
79. Halfter W., Dong S., et al. Composition, synthesis, and assembly of the embryonic chick retinal basal lamina. Dev. Biol. 220 2 (2000) 111-128
80. Hamelin N., Glacet-Bernard A., et al. Surgical treatment of subfoveal neovascularization in myopia: macular translocation vs surgical removal. Am. J. Ophthalmol. 133 4 (2002) 530-536
81. Hawkins B.S., Miskala P.H., Bass E.B., Bressler N.M., Childs A.L., Mangione C.M., and Marsh M.J. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic. II. Quality-of-life findings from a randomized clinical trail: SST Group H Trial: SST Report No. 10. Arch. Ophthalmol. 122 11 (2004) 1616-1628
82. Henkind P., and Gartner S. The relationship between retinal pigment epithelium and the choriocapillaris. Trans. Ophthalmol. Soc. UK 103 Pt 4 (1983) 444-447
83. Ho T.C., and Del Priore L.V. Reattachment of cultured human retinal pigment epithelium to extracellular matrix and human Bruch's membrane. Invest. Ophthalmol. Visual Sci. 38 6 (1997) 1110-1118
84. Hojo M., Abe T., et al. Photoreceptor protection by iris pigment epithelial transplantation transduced with AAV-mediated brain-derived neurotrophic factor gene. Invest. Ophthalmol. Visual Sci. 45 10 (2004) 3721-3726
85. Hsu J.K., Thomas M.A., et al. Clinicopathologic studies of an eye after submacular membranectomy for choroidal neovascularization. Retina 15 1 (1995) 43-52
86. Husain D., Kim I., et al. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. Arch. Ophthalmol. 123 4 (2005) 509-516
87. Jacobson S.G., Cideciyan A.V., et al. Novel mutation in the TIMP3 gene causes Sorsby fundus dystrophy. Arch. Ophthalmol. 120 3 (2002) 376-379
88. Jiang L.Q., Jorquera M., et al. Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts. Exp. Eye Res. 58 6 (1994) 719-728
89. Jonas J.B. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol. Scand. 83 6 (2005) 645-663
90. Kaplan H.J., Tezel T.H., et al. Human photoreceptor transplantation in retinitis pigmentosa. A safety study. Arch. Ophthalmol. 115 9 (1997) 1168-1172
91. Kaplan H.J., Tezel T.H., et al. Retinal pigment epithelial transplantation in age-related macular degeneration. Retina 18 2 (1998) 99-102
92. Kaplan H.J., Del Priore L.V., et al. Retinal Pigment Epithelial Transplantation for Subfoveal Neovascularization in Age-related Macular Degeneration: a Clinical Trial (1998), The Retina Society, Washington, DC
93. Kaplan H.J., Tezel T.H., et al. Retinal transplantation. Chem. Immunol. 73 (1999) 207-219
94. Kertes P.J., and Coupland S.G. The use of subretinal triamcinolone acetonide in the management of neovascular age-related macular degeneration: a pilot study. Can. J. Ophthalmol. 40 5 (2005) 573-584
95. Kim I.K., Husain D., et al. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest. Ophthalmol. Visual Sci. 47 1 (2006) 357-363
96. Korte G.E., Reppucci V., et al. RPE destruction causes choriocapillary atrophy. Invest. Ophthalmol. Visual Sci. 25 10 (1984) 1135-1145
97. Krebs I., Binder S., et al. A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefes Arch. Clin. Exp. Ophthalmol. (2005) 1-5
98. Kuwabara T., Ishikawa Y., et al. Experimental model of gyrate atrophy in animals. Ophthalmology 88 4 (1981) 331-335
99. Lai J.C., Lapolice D.J., et al. Visual outcomes following macular translocation with 360-degree peripheral retinectomy. Arch. Ophthalmol. 120 10 (2002) 1317-1324
100. Lambert H.M., Capone Jr. A., et al. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am. J. Ophthalmol. 113 3 (1992) 257-262
101. Lee C.J., Vroom J.A., et al. Determination of human lens capsule permeability and its feasibility as a replacement for Bruch's membrane. Biomaterials 27 8 (2006) 1670-1678
102. Leonard D.S., Zhang X.G., et al. Clinicopathologic correlation of localized retinal pigment epithelium debridement. Invest. Ophthalmol. Visual Sci. 38 6 (1997) 1094-1109
103. Lewis H., Kaiser P.K., et al. Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study. Am. J. Ophthalmol. 128 2 (1999) 135-146
104. Lin W.L. Immunogold localization of extracellular matrix molecules in Bruch's membrane of the rat. Curr. Eye Res. 8 11 (1989) 1171-1178
105. Liu J., Masurekar M.R., et al. Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart. Am. J. Physiol. Heart Circ. Physiol. 285 6 (2003) H2587-H2591
106. Lois N. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization. Am. J. Ophthalmol. 134 3 (2002) 468 (author reply 468-9)
107. Luke M., Warga M., et al. Effects of bevacizumab ((R)) on retinal function in isolated vertebrate retina. Br. J. Ophthalmol. (2006)
108. Manzano R.P., Peyman G.A., et al. Testing intravitreal toxicity of bevacizumab (Avastin). Retina 26 3 (2006) 257-261
109. Marneros A.G., Keene D.R., et al. Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. Embo J. 23 1 (2004) 89-99
110. Maturi R.K., Bleau L.A., et al. Electrophysiologic findings after intravitreal bevacizumab (Avastin) treatment. Retina 26 3 (2006) 270-274
111. Michels S., and Rosenfeld P.J. [Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis]. Klin. Monatsbl. Augenh. 222 6 (2005) 480-484
112. Michels S., Rosenfeld P.J., et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112 6 (2005) 1035-1047
113. Miller III F.S., Bunt-Milam A.H., et al. Clinical-ultrastructural study of thioridazine retinopathy. Ophthalmology 89 12 (1982) 1478-1488
114. Miller J.W., Schmidt-Erfurth U., et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch. Ophthalmol. 117 9 (1999) 1161-1173
115. Moisseiev J., Alhalel A., et al. The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration. Arch. Ophthalmol. 113 2 (1995) 185-189
116. Mori K., Ando A., et al. Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. Am. J. Pathol. 159 1 (2001) 313-320
117. Moshfeghi A.A., and Puliafito C.A. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration. Expert Opin. Invest. Drugs 14 5 (2005) 671-682
118. Nasir M.A., Sugino I., et al. Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration. Br. J. Ophthalmol. 81 6 (1997) 481-489
119. Ng E.W., Fujii G.Y., et al. Macular translocation in patients with recurrent subfoveal choroidal neovascularization after laser photocoagulation for nonsubfoveal choroidal neovascularization. Ophthalmology 111 10 (2004) 1889-1893
120. Ng E.W., Shima D.T., et al. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug. Discov. 5 2 (2006) 123-132
121. Nicolo M., Ghiglione D., et al. Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Retina 26 1 (2006) 58-64
122. Ohji M., Fujikado T., et al. Comparison of three techniques of foveal translocation in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration. Am. J. Ophthalmol. 132 6 (2001) 888-896
123. Paik D.C., Dillon J., et al. The nitrite/collagen reaction: non-enzymatic nitration as a model system for age-related damage. Connect. Tissue Res. 42 2 (2001) 111-122
124. Park C.H., and Toth C.A. Macular translocation surgery with 360-degree peripheral retinectomy following ocular photodynamic therapy of choroidal neovascularization. Am. J. Ophthalmol. 136 5 (2003) 830-835
125. Pauleikhoff D., Wojteki S., et al. [Adhesive properties of basal membranes of Bruch's membrane. Immunohistochemical studies of age-dependent changes in adhesive molecules and lipid deposits]. Ophthalmologe 97 4 (2000) 243-250
126. Pawlak D., Glacet-Bernard A., et al. Limited macular translocation compared with photodynamic therapy in the management of subfoveal choroidal neovascularization in age-related macular degeneration. Am. J. Ophthalmol. 137 5 (2004) 880-887
127. Penfold P.L., Wen L., et al. Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clin. Exp. Immunol. 121 3 (2000) 458-465
128. Pertile G., and Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am. J. Ophthalmol. 134 4 (2002) 560-565
129. Peyman G.A., Blinder K.J., et al. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. 22 2 (1991) 102-108
130. Pieramici D.J., De Juan Jr. E., et al. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am. J. Ophthalmol. 130 4 (2000) 419-428
131. Pieramici D.J., Bressler S.B., et al. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4. Arch. Ophthalmol. 124 5 (2006) 660-664
132. Pollack J.S., Del Priore L.V., et al. Postoperative abnormalities of the choriocapillaris in exudative age-related macular degeneration. Br. J. Ophthalmol. 80 4 (1996) 314-318
133. Potter M.J., Szabo S.M., et al. Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl. Graefes Arch. Clin. Exp. Ophthalmol. 244 5 (2006) 639-641
134. Rakic J.M., Blaise P., et al. Pegaptanib and age-related macular degeneration. N. Engl. J. Med. 352 16 (2005) 1720-1721 (author reply 1720-1)
135. Rechtman E., Danis R.P., et al. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br. J. Ophthalmol. 88 3 (2004) 344-347
136. Rezai K.A., Kohen L., et al. Iris pigment epithelium transplantation. Graefes Arch. Clin. Exp. Ophthalmol. 235 9 (1997) 558-562
137. Rosa R.H., Thomas M.A., et al. Clinicopathologic correlation of submacular membranectomy with retention of good vision in a patient with age-related macular degeneration. Arch. Ophthalmol. 114 4 (1996) 480-487
138. Rosenfeld P.J. Intravitreal avastin: the low cost alternative to lucentis?. Am. J. Ophthalmol. 142 1 (2006) 141-143
139. Rosenfeld P.J., Fung A.E., et al. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg. Lasers Imaging 36 4 (2005) 336-339
140. Rosenfeld P.J., Moshfeghi A.A., et al. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg. Lasers Imaging 36 4 (2005) 331-335
141. Rosenfeld P.J., Heier J.S., et al. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology 113 4 (2006) 632 (e1)
142. Roth D.B., Estafanous M., et al. Macular translocation for subfoveal choroidal neovascularization in angioid streaks. Am. J. Ophthalmol. 131 3 (2001) 390-392
143. Schraermeyer U., Kayatz P., et al. Transplantation of iris pigment epithelium into the choroid slows down the degeneration of photoreceptors in the RCS rat. Graefes Arch. Clin. Exp. Ophthalmol. 238 12 (2000) 979-984
144. Semkova I., Kreppel F., et al. Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye. Proc. Natl. Acad. Sci. USA 99 20 (2002) 13090-13095
145. Shahar J., Avery R.L., et al. Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina 26 3 (2006) 262-269
146. Shang Q.L., Ma J.X., et al. [Experimental choroidal neovascularization is inhibited by subretinal administration of Endostatin]. Zhonghua Yan Ke Za Zhi 40 4 (2004) 266-271
147. Sheridan C., Williams R., et al. Basement membranes and artificial substrates in cell transplantation. Graefes Arch. Clin. Exp. Ophthalmol. 242 1 (2004) 68-75
148. Smith W., Assink J., et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 108 4 (2001) 697-704
149. Smithen L.M., and Spaide R.F. Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis. Am. J. Ophthalmol. 138 5 (2004) 884-885
150. Spaide R.F., Guyer D.R., et al. External beam radiation therapy for choroidal neovascularization. Ophthalmology 105 1 (1998) 24-30
151. Spaide R.F., Sorenson J., et al. Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization. Retina 25 6 (2005) 685-690
152. Spaide R.F., Sorenson J., et al. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112 2 (2005) 301-304
153. Spraul C.W., Lang G.E., et al. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv. Ophthalmol. 44 Suppl. 1 (1999) S10-S32
154. Stanga P.E., Kychenthal A., et al. Retinal pigment epithelium translocation and central visual function in age related macular degeneration: preliminary results. Int. Ophthalmol. 23 4-6 (2001) 297-307
155. Stanga P.E., Kychenthal A., et al. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology 109 8 (2002) 1492-1498
156. Stur M. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization. Am. J. Ophthalmol. 134 3 (2002) 469-470 (author reply 470-2.)
157. Sullivan F. Pegaptanib was effective and safe without a dose-response relation in neovascular, age-related, macular degeneration. ACP J. Club 143 1 (2005) 18
158. Susic D., Varagic J., et al. Collagen cross-link breakers: a beginning of a new era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertension. Curr. Drug Targets Cardiovasc. Haematol. Disord. 4 1 (2004) 97-101
159. Svojtkova E., Deyl Z., et al. Are the changes in collagen caused by chronical X-irradiation similar to aging?. Physiol. Bohemoslov. 32 5 (1983) 449-459
160. Takahashi M., Suzuki M., et al. The effect of aging and osteoarthritis on the mature and senescent cross-links of collagen in human meniscus. Arthroscopy 14 4 (1998) 366-372
161. Takeuchi M., Itagaki T., et al. [Changes in the intermediate stage of retinal degeneration after intravitreal injection of ornithine]. Nippon Ganka Gakkai Zasshi 97 1 (1993) 17-28
162. Terasaki H. Rescue of retinal function by macular translocation surgery in age-related macular degeneration and other diseases with subfoveal choroidal neovascularization. Nagoya J. Med. Sci. 64 1-2 (2001) 1-9
163. Tezel T.H., and Del Priore L.V. Reattachment to a substrate prevents apoptosis of human retinal pigment epithelium. Graefes Arch. Clin. Exp. Ophthalmol. (Graefes Arch. Klin. Exp. Ophthalmol.) 235 1 (1997) 41-47
164. Tezel T.H., and Del Priore L.V. Repopulation of different layers of host human Bruch's membrane by retinal pigment epithelial cell grafts. Invest. Ophthalmol. Visual Sci. 40 3 (1999) 767-774
165. Tezel T.H., Del Priore L.V., et al. Correlation between scanning laser ophthalmoscope microperimetry and anatomic abnormalities in patients with subfoveal neovascularization. Ophthalmology 103 11 (1996) 1829-1836
166. Tezel T.H., Del Priore L.V., et al. Harvest and storage of adult human retinal pigment epithelial sheets. Curr. Eye Res. 16 8 (1997) 802-809
167. Tezel T.H., Kaplan H.J., et al. Fate of human retinal pigment epithelial cells seeded onto layers of human Bruch's membrane. Invest. Ophthalmol. Visual Sci. 40 2 (1999) 467-476
168. Tezel T.H., Bora N.S., et al. Pathogenesis of age-related macular degeneration. Trends Mol. Med. 10 9 (2004) 417-420
169. Tezel T.H., Del Priore L.V., et al. Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation. Invest. Ophthalmol. Visual Sci. 45 9 (2004) 3337-3348
170. Thomas M.A., and Kaplan H.J. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am. J. Ophthalmol. 111 1 (1991) 1-7
171. Thomas M.A., Grand M.G., et al. Surgical management of subfoveal choroidal neovascularization. Ophthalmology 99 6 (1992) 952-968 (discussion 975-6)
172. Thumann G., Bartz-Schmidt K.U., et al. Transplantation of autologous iris pigment epithelium to the subretinal space in rabbits. Transplantation 68 2 (1999) 195-201
173. Thumann G., Aisenbrey S., et al. Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch. Ophthalmol. 118 10 (2000) 1350-1355
174. Tobin K.A. Macugen treatment for wet age-related macular degeneration. Insight 31 1 (2006) 11-14
175. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized cinical trials-TAP Report 1. Arch. Ophthalmol. 117 10 (1999) 1329-1345
176. Tropepe V., Coles B.L., et al. Retinal stem cells in the adult mammalian eye. Science 287 5460 (2000) 2032-2036
177. Valentino T.L., Kaplan H.J., et al. Retinal pigment epithelial repopulation in monkeys after submacular surgery. Arch. Ophthalmol. 113 7 (1995) 932-938
178. Van de Moere A., Sandhu S.S., et al. Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin. Ophthalmology 112 11 (2005) 1896-1903
179. Weisz J.M., Humayun M.S., et al. Allogenic fetal retinal pigment epithelial cell transplant in a patient with geographic atrophy. Retina 19 6 (1999) 540-545
180. West S.K. Looking forward to 20/20: a focus on the epidemiology of eye diseases. Epidemiol. Rev. 22 1 (2000) 64-70
181. Williams K.A. Transplantation of autologous iris pigment epithelial cells as a treatment for age-related macular degeneration?. Transplantation 68 2 (1999) 171-172
182. Yamauchi M., Woodley D.T., et al. Aging and cross-linking of skin collagen. Biochem. Biophys. Res. Commun. 152 2 (1988) 898-903
183. Ye J., Wang H.M., et al. Allotransplantation of rabbit retinal pigment epithelial cells double-labelled with 5-bromodeoxyuridine (BrdU) and natural pigment. Curr. Eye Res. 12 7 (1993) 629-639